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Abstract
The use of kidneys donated after circulatory death (DCD) remains controversial due to con-
cerns with regard to high incidences of early graft loss, delayed graft function (DGF), and
impaired graft survival. As these concerns are mainly based on data from historical cohorts,
they are prone to time-related effects and may therefore not apply to the current timeframe.
To assess the impact of time on outcomes, we performed a time-dependent comparative
analysis of outcomes of DCD and donation after brain death (DBD) kidney transplantations.
Data of all 11,415 deceased-donor kidney transplantations performed in The Netherlands
between 1990–2018 were collected. Based on the incidences of early graft loss, two eras
were defined (1998–2008 [n = 3,499] and 2008–2018 [n = 3,781]), and potential time-related
effects on outcomes evaluated. Multivariate analyses were applied to examine associations
between donor type and outcomes. Interaction tests were used to explore presence of effect
modification. Results show clear time-related effects on posttransplant outcomes. The
1998–2008 interval showed compromised outcomes for DCD procedures (higher inci-
dences of DGF and early graft loss, impaired 1-year renal function, and inferior graft sur-
vival), whereas DBD and DCD outcome equivalence was observed for the 2008–2018
interval. This occurred despite persistently high incidences of DGF in DCD grafts, and more
adverse recipient and donor risk profiles (recipients were 6 years older and the KDRI
increased from 1.23 to 1.39 and from 1.35 to 1.49 for DBD and DCD donors). In contrast,
the median cold ischaemic period decreased from 20 to 15 hours. This national study shows
major improvements in outcomes of transplanted DCD kidneys over time. The time-
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dependent shift underpins that kidney transplantation has come of age and DCD results are
nowadays comparable to DBD transplants. It also calls for careful interpretation of conclu-
sions based on historical cohorts, and emphasises that retrospective studies should correct
for time-related effects.
Introduction
In the past decades, organs retrieved from donation after brain death (DBD) donors have pro-
vided the majority of solid organ transplants globally. Due to the medical success of transplan-
tation as an effective therapy for patients with end stage organ failure, the increased need of
donor organs created a persistent shortage which has resulted in the death of many patients
while waiting for a transplant.
For many years now, kidneys donated after circulatory death (DCD) have been proposed as
an effective means of addressing this severe organ shortage [1, 2]. Despite emerging reports
indicating that mid-term and long-term outcomes of DCD procedures are better than com-
monly thought [3–5], only some countries have fully embraced this opportunity [6]. For vari-
ous reasons, others have been reluctant or even outspoken adverse towards the introduction of
a controlled DCD programme that could alleviate the shortage and save many lives within a
healthcare system [7, 8]. While for some countries reasons to not or only slowly allow DCD
programmes relate to ethical issues, legal restrictions or logistical concerns [9], for the majority
of countries the reticent attitude generally reflects medical concerns that are based on reported
high incidences of early graft loss, delayed graft function (DGF), and an assumed impaired
graft survival for DCD kidneys.
Since the concerns regarding the inferior DCD outcomes are mainly based on historical
analyses, they are prone to time-related effects as time-varying confounding and effect modifi-
cation by time [10, 11]. Time-varying confounding is the phenomenon that the values of con-
founding variables, such as donor and recipient age, change over time [10]. Effect
modification by time occurs when the effect of donor type on outcomes is modified by time
(e.g. due to changes in procedural characteristics and/or medical decision-making over time)
[11]. Therefore, assumptions as regards inferior outcomes of DCD procedures may not apply
anymore to our current timeframe.
To test whether conclusions with regard to the outcomes of DCD kidney transplant proce-
dures are influenced by time, and to objectify the current results achieved when utilising DCD
donor kidneys, we performed a longitudinal time-dependent comparative analysis of the out-
comes of DBD and DCD kidney transplant procedures performed in The Netherlands, as
country with a longstanding tradition of the use of DCD donor kidneys.
Materials and methods
Patient population
This national outcome evaluation was approved by the Ethics Committee of the Leiden Uni-
versity Medical Center, and the clinical and research activities being reported are consistent
with the Principles of the Declaration of Istanbul as outlined in the ’Declaration of Istanbul on
Organ Trafficking and Transplant Tourism’. Data was fully anonymized prior to access and
analysis.
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In this study, we collected data of all 11,415 deceased-donor kidney transplant procedures
performed in The Netherlands between 1990 and 2018. Combined organ procedures
(n = 635), procedures with grafts donated after uncontrolled circulatory death (i.e. Maastricht
Category I: dead on arrival and II: unsuccessful resuscitation) (n = 212), and procedures in
recipients younger than 12 years old (n = 261) were excluded.
To explore a possible time-related effect, the incidence of early graft loss was mapped for
the years 1990 to 2018. In this analysis, only primary kidney transplant procedures (n = 8,511)
were included since early graft loss after re-transplantation is potentially interfered with accu-
mulation of recipient-related risk factors [12]. Based on the early graft loss incidences, two
timeframes were defined for the time-dependent comparative analysis. This analysis included
all (primary transplantations and re-transplantations) transplantations performed between
1998–2008 (n = 3,499) and 2008–2018 (n = 3,781).
Data was retrieved from the Dutch National Organ Transplant Registry, which is a manda-
tory registry that contains granular data of all eight Dutch kidney transplant centres.
Definitions
Early graft loss was defined as graft loss within 90 days after transplantation. Patients who died
within 90 days after transplantation with a functioning graft were not considered as early graft
loss recipients. DGF was defined as the need for dialysis in the first postoperative week(s). The
Modification of Diet in Renal Disease (MDRD) equation was used to estimate the glomerular
filtration rate (eGFR) in the recipient. The non-scaled, donor-only version of the Kidney
Donor Risk Index (KDRI) was calculated as described by Rao et al. [13]. The following defini-
tions were used for ischaemic periods of the donor kidneys. The first warm ischaemic period is
the time following the no touch period after circulatory arrest and asystole in the DCD donor,
until cold flush-out in the donor is commenced. The cold ischaemic period is the time from
start of cold flush-out until the start of the vascular anastomosis in the recipient. The graft
anastomosis time is defined as the time from kidney removal from static cold storage or hypo-
thermic machine perfusion until reperfusion in the recipient.
Data analysis
IBM SPSS Statistics 23.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis.
Comparisons between DBD and DCD procedures were performed using the independent t-
test for normal-distributed data, the Mann-Whitney rank test for non-parametric data, and
the Chi-Square test for categorical data.
The KDRI was reported to facilitate comparison of the Dutch donor cohort with that of
other countries. However, in the Dutch National Organ Transplant Registry donor hyperten-
sion and diabetes—which are included in the KDRI—are only registered from 2000 respec-
tively 2002 onwards. As such, there was a high proportion of missing data for the 1998–2018
interval (26.6% for diabetes and 10.0% for hypertension) and multiple imputation of missing
data of variables included in the KDRI was applied.
Logistic and linear regression analyses were used to examine the association between out-
comes (DGF, early graft loss and 1-year eGFR) and donor type. Cox proportional hazards
analyses were performed to evaluate differences in patient survival and death censored graft
survival. All the multivariate models were adjusted for variables statistically relevant (p-value
<0.10) in the univariate analysis (S1 Table). To avoid overcorrection the KDRI was not
included in the multivariate models (as the KDRI also comprises donor age and donor type
which are already included separately in the univariate and multivariate analyses). Also the
type of preservation solution was not included as the inter-relationship between variables (the
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selection of preservation solution depends on donor type) would substantially impact the
validity of the model. Results are represented as beta coefficient (β), Odds Ratio (OR) or Haz-
ard Ratio (HR) with the corresponding 95% Confidence Interval (CI).
An interaction (Wald) test was used to explore the presence of effect modification by time.
In other words, to test whether the effect of donor type on outcomes is modified by time. To
specifically determine the association (R2) between KDRI and 5-year graft survival, logistic
regression analysis was performed using the data from 2002 to 2018 (non-imputed). P-values
<0.05 were considered statistically significant.
Results
To explore a possible time-dependent effect on transplant outcomes, we mapped the incidence
of early graft loss, as an unambiguous outcome parameter, for the years 1990 to 2018 in The
Netherlands (Fig 1). Analyses of 5,895 DBD and 2,616 DCD primary kidney transplants per-
formed in this period indicated clear time-related effects with 1998 (DBD) and 2008 (DCD) as
clear transition years, after which the incidence of early graft loss dropped and stabilized at an
incidence of approximately 6% (Fig 1).
Based on the transition years for early graft loss, two timeframes (1998–2008 and 2008–
2018) were defined, and the outcomes of all 7,280 DBD and DCD procedures performed in
these periods were compared accordingly (Tables 1 and 2). This comparison showed a marked
increase in donor and recipient age, and in KDRI over time: donors and recipients were
respectively 6.5 and 6 years older in the recent (2008–2018) timeframe and the KDRI increased
from 1.23 to 1.39 for DBD donors and from 1.35 to 1.49 for DCD donors (Table 1). Although
the KDRI for this Dutch cohort was significantly associated with 5-year graft survival
(p<0.001), the Nagelkerke R2 for the KDRI and 5-year graft loss was only 1.7% suggesting a
limited impact of donor characteristics on graft survival.
In contrast to the increase in donor and recipient age over time, there was a clear decrease
in the cold ischaemic period from a mean value of 20 hours in the 1998–2008 era to approxi-
mately 15 hours in the 2008–2018 era (Table 1). Also the proportion of procedures with exces-
sive cold ischaemic periods (>24 hours) substantially decreased over time (from 25.7% to
7.8% and from 20.1% to 3.2% for DBD respectively DCD donors).
Fig 1. Time-related incidences of early graft loss in 8,511 primary kidney transplant recipients according to deceased donor type in The Netherlands. � The small
number of DCD kidney transplant procedures performed in these years (n< 15), does not justify adequate power for analysis. DBD, donation after brain death; DCD,
donation after circulatory death; EGL, early graft loss.
https://doi.org/10.1371/journal.pone.0236662.g001
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Furthermore, the type of preservation solution changed over time. Whereas histidine-tryp-
tophan-ketoglutarate (HTK) solution was most common for DCD donor kidneys between
1998 and 2008 (86.1%), University of Wisconsin solution was most commonly used between
2008 and 2018 (57.8%) (Table 1).
The comparative outcome analysis showed clear time-related effects (Table 2). Whereas the
1998–2008 era associates with compromised outcomes for DCD procedures in comparison to
DBD procedures (i.e. higher incidences of DGF and early graft loss, impaired 1-year renal
function in patients without DGF, and inferior 1- and 5-year graft survival rates), the 2008–
2018 era shows outcome equivalence for DBD and DCD procedures. Only the incidence of
DGF for DCD grafts remained high in the current era (Table 2), but this did not impact graft
and patient survival. Yet, for both timeframes and for both donor types, DGF resulted in a
15% reduced 1-year renal function (Table 2).
To explore whether the shift towards outcome equivalence reflects effect modification by
time, an interaction (Wald) test was performed. As expected, the interaction test confirmed a
significant difference in the effect of donor type on outcomes (DGF, early graft loss, 1- and
5-year graft survival) between the two time eras (p for interaction: <0.001, 0.002, 0.001 and
<0.001, respectively) (Table 2).
Discussion
This national study demonstrates a major improvement in outcomes of transplanted DCD
kidneys over time. Whereas the 1998–2008 era associates with inferior outcomes for DCD kid-
ney transplant procedures, the 2008–2018 era shows outcome equivalence between DBD and
DCD kidney transplants. This shift underpins that DCD kidney transplantation has come of
Table 1. Baseline characteristics of deceased-donor kidney transplants in The Netherlands for the 1998–2008 and the 2008–2018 interval.
01/1998–12/2007 01/2008–12/2017
DBD DCD p-value DBD DCD p-value p for interaction
n = 2361 (67.5%) n = 1138 (32.5%) n = 1929 (51.0%) n = 1852 (49.0%)
BASELNIE Donor age 46.2 ± 15.3 45.4 ± 15.4 0.16 52.7 ± 14.6 51.6 ± 14.5 0.03 <0.001
Recipient age 48.6 ± 14.3 50.7 ± 13.3 <0.001 55.0 ± 14.2 55.9 ± 12.9 0.03 <0.001
Time on dialysis (years) 4.1 ± 2.5 4.2 ± 2.0 0.24 3.8 ± 2.5 3.6 ± 2.1 0.001 <0.001
First warm ischaemic period
(min.)
NA 19.0 [15.0–25.0] - NA 16.0 [13.0–19.0] - -
Cold ischaemic period (hours) 20.0 [15.6–24.6] 20.0 [16.0–23.8] 0.32 15.4 [11.8–19.8] 14.0 [11.5–17.6] <0.001 <0.001
�24 hours 1705 (74.3%) 889 (79.9%) 1589 (92.2%) 1575 (96.8%)
>24 hours 589 (25.7%) 224 (20.1%) 135 (7.8%) 52 (3.2%)
Graft anastomosis time (min.) 34.0 [27.0–41.0] 33.0 [27.0–40.0] 0.32 33.0 [26.0–41.0] 32.0 [25.0–40.0] 0.01 0.01
KDRI 1 1.23 [1.0–1.5] 1.35 [1.1–1.6] <0.001 1.39 [1.1–1.7] 1.49 [1.2–1.8] <0.001 <0.001
Preservation solution <0.001 <0.001 <0.001
- HTK 325 (13.9%) 967 (86.1%) 463 (24.4%) 719 (39.3%)
- University of Wisconsin 2001 (85.4%) 152 (13.5%) 1383 (72.8%) 1058 (57.8%)
- Other 17 (0.7%) 4 (0.4%) 55 (2.9%) 53 (2.9%)
Data are respectively presented as mean ± standard deviation, as number (%), as median [interquartile range] or as beta coefficient (β), odds ratio or hazard ratio with
the corresponding 95% confidence interval.
1 Multiple imputation was applied for missing data of variables included in the KDRI.
DBD, donation after brain death; DCD, donation after circulatory death; HTK, histidine-tryptophan-ketoglutarate; KDRI, kidney donor risk index; min., minutes; NA,
not applicable.
https://doi.org/10.1371/journal.pone.0236662.t001
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age and results are nowadays comparable to DBD kidney transplants. It also emphasises that
conclusions based on retrospective data (i.e. based on timeframes in which outcomes of DCD
procedures were inferior to DBD procedures) are interfered by time-varying confounding and
effect modification, and are therefore no longer justified.
Patient- and graft survival equivalence for DBD and DCD procedures occurred despite a
persistent high incidence of DGF in DCD grafts. This apparent paradox can be explained by
differential impacts of DGF on DBD and DCD outcomes, with a negligible impact of DGF on
patient- and graft survival in recipients with DCD grafts [4, 14]. A phenomenon that presum-
ably relates to donor type-specific molecular differences in organ resilience [14].
A clear, univocal explanation for the improved outcomes is missing. In the context of more
adverse donor and recipient risk profiles in the more recent timeframe, the improvement in
Table 2. Deceased-donor kidney transplant outcomes in The Netherlands for the 1998–2008 and the 2008–2018 interval.
01/1998–12/2007 01/2008–12/2017
DBD DCD p-value DBD DCD p-value p for interaction
n = 2361 (67.5%) n = 1138 (32.5%) n = 1929 (51.0%) n = 1852 (49.0%)
OUTCOME Delayed graft function 420 (17.8%) 511 (44.9%) <0.001 321 (16.6%) 736 (39.7%) <0.001
Crude OR (95% CI) Ref. 4.04 (3.42–4.78) <0.001 Ref. 3.85 (3.28–4.53) <0.001 <0.001
Adjusted OR (95% CI) Ref. 4.17 (3.45–5.04) <0.001 Ref. 4.78 (3.99–5.70) <0.001
Early graft loss (<day 90) 194 (8.2%) 151 (13.3%) <0.001 110 (5.7%) 114 (6.2%) 0.56
Crude OR (95% CI) Ref. 1.71 (1.36–2.14) <0.001 Ref. 1.09 (0.83–1.42) 0.56 0.002
Adjusted OR (95% CI) Ref. 1.77 (1.40–2.23) <0.001 Ref. 1.24 (0.92–1.68) 0.16
- Primary non-function 44 (22.7%) 58 (38.4%) 42 (38.2%) 43 (37.7%)
- Rejection 58 (29.9%) 25 (16.6%) 23 (20.9%) 20 (17.5%)
- Thrombosis or infarction 38 (19.6%) 36 (23.8%) 14 (12.7) 24 (21.1%)
- Other 54 (27.8%) 32 (21.2%) 31 (28.2%) 27 (23.7%)
1-year eGFR DGF - 52.6 ± 19.7 49.5 ± 18.1 0.02 51.5 ± 19.7 52.3 ± 20.0 0.44
Crude β (95% CI) Ref. -3.07 (-5.67 - -0.47) 0.02 Ref. 0.84 (-1.29–2.96) 0.44 0.93
Adjusted β (95% CI) Ref. -4.21 (-6.57 - -1.86) <0.001 Ref. -0.11 (-2.04–1.82) 0.91
1-year eGFR DGF + 44.1 ± 19.0 44.4 ± 18.4 0.81 44.8 ± 18.9 44.6 ± 17.5 0.89
Crude β (95% CI) Ref. 0.32 (-2.19–2.82) 0.81 Ref. -0.18 (-2.81–2.45) 0.89 0.70
Adjusted β (95% CI) Ref. -0.69 (-3.02–1.63) 0.56 Ref. -1.63 (-4.05–0.79) 0.19
1-year graft loss (10.9%) (15.0%) (8.0%) (7.9%)
Crude HR (95% CI) 1.0 1.41 (1.16–1.71) 0.001 1.0 0.98 (0.78–1.23) 0.84 0.001
Adjusted H R (95% CI) 1.0 1.45 (1.19–1.77) <0.001 1.0 1.09 (0.85–1.40) 0.49
5-year graft loss (20.0%) (22.8%) (14.0%) (13.6%)
Crude HR (95% CI) 1.0 1.18 (1.01–1.37) 0.04 1.0 0.96 (0.80–1.15) 0.66 <0.001
Adjusted HR (95% CI) 1.0 1.25 (1.07–1.46) 0.01 1.0 1.04 (0.85–1.27) 0.69
1-year patient survival (95.0%) (94.4%) (95.2%) (94.8%)
Crude HR (95% CI) 1.0 1.14 (0.84–1.54) 0.41 1.0 1.08 (0.82–1.43) 0.58 0.60
Adjusted HR (95% CI) 1.0 1.08 (0.80–1.46) 0.62 1.0 1.08 (0.81–1.42) 0.61
5-year patient survival (82.8%) (82.4%) (82.3%) (82.5%)
Crude HR (95% CI) 1.0 1.04 (0.88–1.23) 0.66 1.0 1.00 (0.85–1.17) 0.96 0.81
Adjusted HR (95% CI) 1.0 1.08 (0.89–1.30) 0.44 1.0 1.02 (0.85–1.22) 0.83
Data are respectively presented as mean ± standard deviation, or as number (%), and beta coefficient (β), odds ratio or hazard ratio with the corresponding 95%
confidence interval.
95% CI, 95% confidence interval; DBD, donation after brain death; DCD, donation after circulatory death; DGF, delayed graft function; eGFR, estimated glomerular
filtration rate; HR, hazard ratio; min., minutes; OR, odds ratio.
https://doi.org/10.1371/journal.pone.0236662.t002
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DCD outcomes over time presumably involves a complex interplay of factors that includes
optimized surgical procedures and immunosuppressive regimens, altered organ preservation
techniques, and enhanced transport logistics [15–19]. Certainly, a significant impact has been
the profound reduction in cold ischaemic time [16, 20]. Several studies have shown that a pro-
longed cold ischaemic time is more deleterious in recipients receiving kidney transplants from
DCD donors than in recipients from DBD donors [21–23]. This finding, with DCD grafts
being more ‘vulnerable’ to cold ischaemia than DBD grafts, has recently been confirmed by
colleagues in The Netherlands [20], and might also explain why graft survival rates have
improved to a greater extent for recipients of DCD donors than for recipients of DBD donors.
Another possible explanation is that—as cold ischaemic periods of more than 24 hours in
DCD kidneys are associated with worse graft survival—the proportion of procedures with
excessive cold ischaemic periods (>24 hours) decreased over time with the increasing aware-
ness of avoiding long cold ischaemic times in the Netherlands [4]. A potential contribution of
hypothermic machine perfusion (HMP) to improved outcomes, however, is limited in this
Dutch cohort since HMP was only fully implemented in the year 2016, and as the available
data indicate that although HMP reduces the risk of DGF, it has a limited impact on the other
outcome data [24].
Improved outcomes over time may further reflect advances in immunosuppressive thera-
pies including the conversion from cyclosporine to tacrolimus as standard maintenance
regime [25, 26]. Also, the introduction of more sensitive techniques to detect anti-human leu-
kocyte antigen antibodies, such as the LUMINEX technique may have resulted in increased
graft survival [18].
An alternative and non-exclusive explanation for the improved outcomes is the presence of
a learning curve that involves the intangible and often intuitive aspects of medical decision-
making processes in the context of donor and recipient selection, and organ allocation. Exis-
tence of a learning curve phenomenon is supported by the observation that outcomes of trans-
planted DBD kidneys improved significantly in a similar way as for DCD transplant
procedures, but at an earlier (1990–1998) time era, and by the dynamics of the incidence of
early graft loss over time (Fig 1). To be more specific, data for DBD procedures show a steep
decline and stabilization of the incidence of early graft loss after 1998. A similar—albeit post-
poned—pattern is seen for the DCD procedures, for which the early graft loss incidence rate
dropped and stabilized following 2008. Thus, it is likely that countries initiated a controlled
DCD programme, may also experience some form of learning curve with transient inferior
outcomes for this type of transplant procedure.
Remarkably, the time-related improvements in DCD outcomes occurred despite consider-
able increases in donor and recipient age, and in KDRI over time (Table 1). The apparent para-
dox of increasing KDRI values but improving graft survival rates suggests that, after the
medical decision to accept a kidney for donation, there is a limited impact of donor character-
istics on graft survival. This is illustrated by the remarkably low Nagelkerke R2 for the associa-
tion between KDRI and 5-year graft survival [13]. Hence, these data illustrate that graft
survival reflects an interplay of donor, procedural and recipient factors [15].
This study has some limitations. Firstly, it is a registry-based study, which is associated with
inherent design limitations. Secondly, this is a country-specific study as outcomes are influ-
enced by national guidelines and decision-making policies. However, considering the liberal
attitude towards DCD kidneys in The Netherlands (reflected by an equal distribution in DBD
and DCD procedures, comparable donor ages and KDRI values) it is unlikely that the results
reflect a high threshold in accepting DCD grafts.
In conclusion, this registry-based study shows a major improvement in outcomes of trans-
planted DCD kidneys over time, with DBD and DCD outcome equivalence in the current
PLOS ONE A time-dependent comparative analysis of the outcomes of DCD and DBD kidney transplant procedures
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timeframe. The time-related improvements for DCD outcomes not only show that DCD kid-
neys can be fully embraced, but also emphasise that careful interpretation is required for con-
clusions that are based on historical cohorts.
Supporting information
S1 Table. Multivariate analyses of posttransplant outcomes. In total 16 multivariate analyses
were performed. Each row represents a single multivariate analysis. The multivariate models
were adjusted for variables that were statistically relevant in the univariate analysis (p-value
<0.1). (-) Indicates that the variable was not included in the multivariate analysis. (�) p-value
<0.05, (��) p-value <0.005. 95% CI, 95% confidence interval; DGF, delayed graft function;
eGFR, estimated glomerular filtration rate; HR, hazard ratio; OR, odds ratio.
(DOCX)
Acknowledgments
We thank the Dutch Transplant Foundation (Nederlandse Transplantatie Stichting) for pro-
viding the data.
Author Contributions
Conceptualization: Michèle J. C. de Kok, Alexander F. M. Schaapherder, Aiko P. J. de Vries,
Jan H. N. Lindeman.
Formal analysis: Michèle J. C. de Kok.
Methodology: Michèle J. C. de Kok, Alexander F. M. Schaapherder, Esther Bastiaannet, Jan H.
N. Lindeman.
Supervision: Alexander F. M. Schaapherder, Ian P. J. Alwayn, Jan H. N. Lindeman.
Writing – original draft: Michèle J. C. de Kok, Alexander F. M. Schaapherder, Jan H. N.
Lindeman.
Writing – review & editing: Alexander F. M. Schaapherder, Ian P. J. Alwayn, Frederike J.
Bemelman, Jacqueline van de Wetering, Arjan D. van Zuilen, Maarten H. L. Christiaans,
Marije C. Baas, Azam S. Nurmohamed, Stefan P. Berger, Esther Bastiaannet, Rutger J.
Ploeg, Aiko P. J. de Vries, Jan H. N. Lindeman.
References
1. DeVita MA, Snyder JV, Grenvik A. History of organ donation by patients with cardiac death. Kennedy
Inst Ethics J. 1993; 3: 113–129. https://doi.org/10.1353/ken.0.0147 PMID: 10126525
2. Bendorf A, Kelly PJ, Kerridge IH, McCaughan GW, Myerson B, Stewart C, et al. An international com-
parison of the effect of policy shifts to organ donation following cardiocirculatory death (DCD) on dona-
tion rates after brain death (DBD) and transplantation rates. PLoS One. 2013; 8: e62010. https://doi.
org/10.1371/journal.pone.0062010 PMID: 23667452
3. Brook NR, White SA, Waller JR, Veitch PS, Nicholson ML. Non-heart beating donor kidneys with
delayed graft function have superior graft survival compared with conventional heart-beating donor kid-
neys that develop delayed graft function. Am J Transplant. 2003; 3: 614–618. https://doi.org/10.1034/j.
1600-6143.2003.00113.x PMID: 12752318
4. Schaapherder AF, Wijermars LG, de Vries DK, de Vries AP, Bemelman FJ, van de Wetering J, et al.
Equivalent long-term transplantation outcomes for kidneys donated after brain death and cardiac death:
Conclusions from a nationwide evaluation. EClinicalMedicine. 2018; 4–5: 25–31. https://doi.org/10.
1016/j.eclinm.2018.09.007 PMID: 31193600
PLOS ONE A time-dependent comparative analysis of the outcomes of DCD and DBD kidney transplant procedures
PLOS ONE | https://doi.org/10.1371/journal.pone.0236662 July 29, 2020 8 / 10
5. Summers DM, Watson CJ, Pettigrew GJ, Johnson RJ, Collett D, Neuberger JM, et al. Kidney donation
after circulatory death (DCD): state of the art. Kidney Int. 2015; 88: 241–249. https://doi.org/10.1038/ki.
2015.88 PMID: 25786101
6. Weiss J, Elmer A, Mahı́llo B, Domı́nguez-Gil B, Avsec D, Nanni Costa A, et al. Evolution of deceased
organ donation activity versus efficiency over a 15-year period: an international comparison. Transplan-
tation. 2018; 102: 1768–1778. https://doi.org/10.1097/TP.0000000000002226 PMID: 29677069
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